Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Guanfacine, Lisdexamfetamine; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 6 Years to 17 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy, Hypercapnia
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: Not listed
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cognitive Function
Interventions: aerobic training, stretching/toning; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 20 Years to 68 Years
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Functional Abdominal Pain Syndrome, Anxiety
Interventions: ADAPT; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 11 Years to 16 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Depression
Interventions: Behavioral Activation Therapy, Baseline assessment procedures; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 15 Years to 17 Years
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Cocaine Use Disorder
Interventions: Cariprazine Oral Capsule [Vraylar], Placebo oral capsule; Drug
Lead sponsor: Anna Rose Childress, Ph.D.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Magnetic Resonance Imaging, Cognition, Nicotine, Mecamylamine
Interventions: Placebo, Nicotine, Mecamylamine; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 21 Years to 50 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Major Depressive Disorder
Interventions: active tVNS, Sham tVNS; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years to 65 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Cognitive Impairment, Cognitive Decline
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: University of Florida; Other
Eligibility: 60 Years to 95 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Alcohol Use Disorder
Interventions: Mifepristone, Placebo - Cap; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 55 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aging, Anxiety, Memory Impairment
Interventions: Anticipatory psychological stress; Behavioral
Lead sponsor: Georgia Institute of Technology; Other
Eligibility: 65 Years to 80 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Tongue Carcinoma
Interventions: MRI; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years to 75 Years
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Restricted Diet, Ruse Diet; Dietary Supplement
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 9 Years to 12 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Anxiety, Healthy Volunteers
Interventions: Shock or startle device; Device
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Auditory Perception
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Traumatic Brain Injury, Attention Deficit Disorder
Interventions: Vyvanse, fMRI, Placebo; Drug · Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 16 Years to 45 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Post-Traumatic Stress Disorder
Interventions: Seroquel; Drug
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 18 Years to 65 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Somerville, Massachusetts

Conditions: Depression
Interventions: Neuroimaging with Magnetic Resonance Imaging (MRI); Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Bulimia Nervosa
Interventions: Not listed
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Cognitive Ability, General
Interventions: Cognitive Training - 48 sessions, Fitness, Active Control, active tDCS, sham tDCS, Cognitive Training - 20 sessions; Behavioral · Device
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 44 Years
Enrollment: 521 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis
Interventions: Acoramidis (AG10) oral tablet; Drug
Lead sponsor: Eidos Therapeutics, a BridgeBio company; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pre-Eclampsia, Neurocognitive Dysfunction
Interventions: Neuroimaging Procedures, Neuropsychological Assessment Procedures; Diagnostic Test
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Nicotine Dependence
Interventions: Belsomra, Placebo, Methylphenidate; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: IgA Nephropathy (IgAN), Immunoglobulin A Nephropathy (IgAN)
Interventions: atrasentan; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD

Role of Prostaglandins in the Regulation of Brain Blood Flow

Cognitive Benefits of Aerobic Exercise Across the Age Span

Neural Mechanisms of Treatment Response to ADAPT

Mechanisms of Behavioral Activation (BA)

Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder

Nicotinic Modulation of the Default Network

Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression

Neuromodulation Effects in Older Adults

INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers

Neurobiological Mechanisms of Aging and Stress on Prospective Navigation

Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging

Neuroimaging of Diet in ADHD: Phase I

Identifying Decision Making Parameters in Healthy Volunteers and Anxiety Patients

Brain Activation During Simple Vocal Behaviors

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits

Post-Traumatic Stress Disorder (PTSD) and Seroquel

fMRI Accelerated TMS Depression

Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa

INSIGHT, A Comprehensive, Multidisciplinary Brain Training System

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia

Orexin s Role in the Neurobiology of Substance Use Disorder

Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)